GlassScriptPhysician profile
John M Schwartzberg
NPI 1669823878
$1,347.67
in general payments reported to CMS, 2019-2025
13 companies · $87.11 in 2025
The $87.11 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $295 · 2021: $422 · 2022: $85.46 · 2025: $87.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $355.82 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.13 | 2019-2025 | Jardiance |
| Gilead Sciences, INC. | $123.94 | 2020-2021 | |
| Pfizer INC. | $118.72 | 2020-2022 | |
| Lilly USA, LLC | $118.21 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $111.48 | 2020-2022 | |
| Amarin Pharma, INC. | $92.99 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $76.18 | 2021-2025 | Airsupra |
| Esperion Therapeutics, INC. | $51.62 | 2020-2021 | |
| Abbott Laboratories | $17.31 | 2021 | |
| Daiichi Sankyo INC. | $17.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2020 | |
| Philips North America LLC | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schwartzberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.